S100B urine concentrations in late preterm infants are gestational age and gender dependent

Clinica Chimica Acta

Volumn 417, Issue , 2013, Pages 31-34

  Sannia, Andrea ^a   Risso, Francesco Maria ^a,b   Zimmermann, Luc J I ^c   Gavilanes, Antonio W D ^c   Vles, Hans J ^c   Gazzolo, Diego ^b  

^a G GASLINI INSTITUTE   (Italy)

^b C Arrigo Children's Hospital   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Biomarkers; Brain development; Late preterm; S100B

Indexed keywords

PROTEIN S100B;

ARTICLE; BRAIN DAMAGE; CLINICAL FEATURE; CLINICAL LABORATORY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; IMMUNOLUMINOMETRIC ASSAY; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROTROPISM; PATIENT MONITORING; PREMATURITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REFERENCE VALUE; SEX DIFFERENCE;

ADULT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; NERVE GROWTH FACTORS; PREGNANCY; REFERENCE VALUES; S100 PROTEINS; SEX CHARACTERISTICS; TIME FACTORS;

EID: 84872414153     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.013     Document Type: Article

References (36)

1. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2006. Natl Vital Stat Rep 2009, 57:1-104.
2. Davidoff M.J., Dias T., Damus K., et al. Changes in gestational age distribution among U.S. singleton births: impact on rates of late preterm birth 1992-2002. Semin Perinatol 2006, 30:8-15.
3. Shapiro-Mendoza C.K., Tomashek K.M., Kotelchuck M., et al. Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk. Pediatrics 2008, 121(2).
4. Tomashek K.M., Shapiro-Mendoza C.K., Davidoff M.J., Petrini J.R. Differences in mortality between late-preterm and term singleton infants in the United States, 1995-2002. J Pediatr 2007, 151:450-456.
5. Huppi P.S., Warfield S., Kikinis R., et al. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 1998, 43:224-235.
6. Guihard-Costa A.M., Larroche J.C. Differential growth between the fetal brain and its infratentorial part. Early Hum Dev 1990, 23:27-40.
7. Michetti F., Corvino V., Geloso M.C., et al. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012, 120:644-659.
8. Heizmann C.W. Ca-binding S100 proteins in the central nervous system. Neurochem Res 1999, 24:1097-1100.
9. Van Eldik L.J., Wainwright M.S. The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain. Restor Neurol Neurosci 2003, 21:97-108.
10. Gazzolo D., Bruschettini M., Corvino V., et al. S100b protein concentrations in amniotic fluid correlate with gestational age and with cerebral ultrasound scanning results in healthy fetuses. Clin Chem 2001, 47:954-956.
11. Gazzolo D., Vinesi P., Marinoni E., et al. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem 2000, 46:998-1000.
12. Gazzolo D., Michetti F., Bruschettini M., et al. Pediatric concentrations of S100B protein in blood: age- and sex-related changes. Clin Chem 2003, 49:967-970.
13. Gazzolo D., Bruschettini M., Lituania M., et al. S100b protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns. Clin Chem 2001, 47:1132-1133.
14. Gazzolo D., Lituania M., Bruschettini M., et al. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 2005, 38:229-333.
15. Steiner J., Schiltz K., Walter M., et al. S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology 2010, 35:321-324.
16. Nygaard Ø., Langbakk B., Romner B. Age- and sex-related changes of S100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorders. Clin Chem 1997, 43:541-543.
17. Gazzolo D., Frigiola A., Bashir M., et al. Diagnostic accuracy of S100B urinary testing at birth in full-term asphyxiated newborns to predict neonatal death. PLoS One 2009, 4:e4298.
18. Gazzolo D., Marinoni E., Di Iorio R., et al. Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants. Crit Care Med 2004, 32:131-136.
19. Gazzolo D., Marinoni E., Di Iorio R., et al. Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants. Arch Pediatr Adolesc Med 2003, 157:1163-1168.
20. Gazzolo D., Bruschettini M., Lituania M., et al. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 2001, 47:1836-1838.
21. Gazzolo D., Kornacka M., Bruschettini M., et al. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood and urine of preterm infants. Clin Chem 2003, 49:1215-1218.
22. Campbell S., Thoms A. Ultrasound measurement of the fetal head to abdomen circumference ratio in the assessment of growth retardation. Br J Obstet Gynaecol 1977, 84:165-174.
23. Prechtl H.F.R. Assessment methods for the newborn infant: a critical evaluation. Psychobiology of the human newborn 1982, 21-52. Wiley, Chichester. D. Stratton (Ed.).
24. Slattery M.M., Morrison J.J. Preterm delivery. Lancet 2002, 360:1489-1497.
25. Hamilton B.E., Martin J.A., Ventura S.J. Births: preliminary data for 2005 2006, Health E-Stats, Hyattsville,MD, http://www.cdc.gov/nchs/products/pubs/pubd/hestats/prelimbirths05/prelimbirths05.
26. Ma X., Huang C., Shouzeng L., et al. The clinical outcomes of late preterm infants: a multi-centre survey of Zhejiang, China. J Perinat Med 2009, 37:695-699. Provincial Collaborative Study Group for Late-Preterm Infants.
27. McCall E., Craig S., Neonatal Intensive Care Outcomes Research, Evaluation (NICORE) Steering Group Neonatal care in Northern Ireland 2006 2009, Neonatal Intensive Care Outcomes Research and Evaluation Group, Belfast, Northern Ireland.
28. Lauriola L., Coli A., Cocchia D., et al. Comparative study by S-100 and GFAP immunohistochemistry of glial cell population in the early stages of human spinal cord development. Brain Res 1987, 465:251-255.
29. Zuckerman J.E., Herschman H.R., Levine L. Appearance of a brain specific antigen (th S-100 protein) during human foetal development. J Neurochem 1970, 17:247-251.
30. Haynes R.L., Borenstein N.S., De Silva, et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 2005, 484:156-167.
31. Back S.A., Luo N.L., Borenstein, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001, 21:1302-1312.
32. Tina L.G., Frigiola A., Abella R., et al. Near infrared spectroscopy in healthy preterm and term newborns: correlation with gestational age and standard monitoring parameters. Curr Neurovasc Res 2009, 6:148-154.
33. Gazzolo D., Di Iorio R., Marinoni E., et al. S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage. Crit Care Med 2002, 30:1356-1360.
34. Gerlai R., Roder J. Female specific hyperactivity in S100b transgenic mice does not habituate in open-field. Behav Brain Res 1993, 59:119-124.
35. Gazzolo D., Marinoni E., Di Iorio R., et al. Circulating S100B protein is increased in intrauterine growth retarded fetuses. Pediatr Res 2002, 51:215-219.
36. Kent A.L., Wright I.M., Abdel-Latif M.E., New South Wales and Australian Capital Territory Neonatal Intensive Care Units Audit Group Mortality and adverse neurologic outcomes are greater in preterm male infants. Pediatrics 2012, 129:124-131.